Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (491-500 of 910) with videos related to

Pageof 91
Sort By:
Plos One|September 15, 2009
Gene expression patterns in peripheral blood correlate with the extent of coronary artery diseasePeter R Sinnaeve, Mark P Donahue, Peter Grass, et al.
European Heart Journal|July 1, 2005
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromesStefano Savonitto, Mauricio G Cohen, Alessandro Politi, et al.
The American Journal of Medicine|August 9, 2005
Medication performance measures and mortality following acute coronary syndromesChristopher B Granger, Philippe Gabriel Steg, Eric Peterson, et al.
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
The American Journal of Medicine|January 25, 2006
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarctionRajendra H Mehta, David Marks, Robert M Califf, et al.
European Journal of Heart Failure|September 6, 2016
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustmentNathaniel M Hawkins, Pardeep S Jhund, Andrea Pozzi, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
European Journal of Heart Failure|February 13, 2018
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrumLars H Lund, Brian Claggett, Jiankang Liu, et al.
Circulation|September 19, 2022
Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE TrialSana M Al-Khatib, Daniel M Wojdyla, Christopher B Granger, et al.
Journal of the American College of Cardiology|January 5, 2002
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromesStefano Savonitto, Christopher B Granger, Diego Ardissino, et al.
Pageof 91

Showing results (491-500 of 910) with videos related to

Sort By:
Pageof 91
Plos One|September 15, 2009
Gene expression patterns in peripheral blood correlate with the extent of coronary artery diseasePeter R Sinnaeve, Mark P Donahue, Peter Grass, et al.
European Heart Journal|July 1, 2005
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromesStefano Savonitto, Mauricio G Cohen, Alessandro Politi, et al.
The American Journal of Medicine|August 9, 2005
Medication performance measures and mortality following acute coronary syndromesChristopher B Granger, Philippe Gabriel Steg, Eric Peterson, et al.
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
The American Journal of Medicine|January 25, 2006
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarctionRajendra H Mehta, David Marks, Robert M Califf, et al.
European Journal of Heart Failure|September 6, 2016
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustmentNathaniel M Hawkins, Pardeep S Jhund, Andrea Pozzi, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
European Journal of Heart Failure|February 13, 2018
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrumLars H Lund, Brian Claggett, Jiankang Liu, et al.
Circulation|September 19, 2022
Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE TrialSana M Al-Khatib, Daniel M Wojdyla, Christopher B Granger, et al.
Journal of the American College of Cardiology|January 5, 2002
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromesStefano Savonitto, Christopher B Granger, Diego Ardissino, et al.
Pageof 91